1 / 15

Counterfeit Drugs : A CLEAR AND PRESENT DANGER

Counterfeit Drugs : A CLEAR AND PRESENT DANGER. State Senator Marvin Riegsecker, R.Ph. Prevalence of Drug Counterfeiting. Counterfeit drugs are more prevalent in developing countries. According to the World Health Organization (WHO): A. Industrialized Countries: 22%

indivar
Télécharger la présentation

Counterfeit Drugs : A CLEAR AND PRESENT DANGER

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Counterfeit Drugs: A CLEAR AND PRESENT DANGER State Senator Marvin Riegsecker, R.Ph.

  2. Prevalence of Drug Counterfeiting Counterfeit drugs are more prevalent in developing countries. According to the World Health Organization (WHO): A. Industrialized Countries: 22% B. Developing Countries: 78% Africa: 50-60% China: 50% Mexico, Argentina, Columbia: 40% Brazil: 30-40% India: 15-20%

  3. Trends in Counterfeit Drug Cases Number of open FDA Cases

  4. What is a Counterfeit Drug? According to WHO: “[A] product that is deliberately and fraudulently mislabeled with respect to identity and source.”

  5. Where is the problem? Drug counterfeiting isn’t a manufacturing problem, it is a distribution problem.

  6. Red arrows indicate secondary (gray) market

  7. Example 1: Lipitor According to WHO: “ [A] product that is deliberately and fraudulently mislabeled with respect to identity and source.”

  8. Lipitor: Which pill is authentic?

  9. Example 2: Epogen probable sales unknown sources and sales confirmed sales Amgen Drugmaker 2,000 U/mL MANUFACTURER NATIONAL WHOLESALER Epogen Trail to Timothy Fagan Cardinal 8,931boxes 2,000 U/mL AmerisourceBergen 3,363 boxes 2,000 U/mL PHARMACY J&M Pharmacare FL Pharmacy Bought 12,294 boxes 2,000 U/mL GRAY MARKET Armando Rodriguez FL Go-between 12,294 boxes 2,000 U/mL Printer in Hialeah Made Counterfeit Labels Silvino Cristobal Morales Relabeled Vials Coastal Medical VA Wholesaler 135 Boxes Lot 2970 Jose Grillo Alleged FL Counterfeiter 2,000 U/mL 40,000 U/mL Double J Unlicensed FL Wholesaler Playpen South FL Strip Club Nick Just/ Paul Perito Tradewinds Trading TX Wholesaler 135 Boxes Lot 2970 AD Pharmaceutical FL Wholesaler 2 Boxes Lot 2970 Y W Consultants Unlicensed FL Wholesaler Rebel Dist CA Wholesaler Grapevine Trading OH Wholesaler Medix Intl Carlos Luis TX Shell Co. 180 Boxes Lot 2970 Ivan Villarchao FL 45 Boxes Lot 2970 Armin Medical24 Nashua, NH 129 Boxes Lot 2970 Express RX Eddie Mor Texas Shell Co. 180 Boxes Lot 2970 Premier Medical Group GA Shell Co. 460 Boxes Lot 1091 812 Boxes Lot 2970 Optia Medical Mark Novosel UT Shell Co. 45 Boxes Lot 2970 Jemco Medical FL Wholesaler 16 Boxes Lot 2970 AmeRx Susan Cavalieri FL Wholesaler 182 Boxes Lot 2970 CSG TN Wholesaler 812 Boxes Lot 2970 CSG TN Wholesaler 460 Boxes Lot 1091 REGIONAL WHOLESALER Dialysist West AZ Wholesaler 1056 Boxes, Lot 2970 Dialysist West AZ Wholesaler 461 Boxes, Lot 1091 NATIONAL WHOLESALER AmerisourceBergen KY Distribution Center 1517 Boxes PHARMACY CVS, NY PATIENT Timothy Fagan

  10. Example 3: TamifluFighting Fake Flu Pills

  11. What can be done? • Federal Regulation of Wholesale Distributors: • Prescription Drug Marketing Act (PDMA) of 1987, Prescription Drug Amendments (PDA) of 1992 • Banned the Sale of Drug Samples and Drug Coupons • Banned Reimportation (limited exceptions) • Set Requirements for Sample Distribution and Storage • Required State Licensing of Wholesale Distributors • Required Identity Statements for Sales (pedigree) by Unauthorized Distributors of Record

  12. What can be done? • State Licensing of Wholesale Distributors: • State Boards of Pharmacy • Renewal Schedule: One to Two years • Out-of-State Wholesale Distributors • Regulatory Challenges • Limited Board of Pharmacy Resources • Lack of Uniformity of States’ Regulation • Lack of Communication Between Regulators

  13. Indiana’s New WDD Law Increases penalties for counterfeiting Rx drugs and distributing contraband drugs Creates rigorous licensing requirements including mandatory accreditation for all wholesalers Determines a “Normal Chain of Distribution” (NCOD) Requires pedigree for all drugs distributed outside of NCOD

  14. Indiana’s New WDD Law Mandatory National Accreditation VAWD® or other Board Approved Accreditation Accreditation will ensure compliance with relevant state and federal laws Newly issued licensees must obtain Accreditation prior to issuance Existing license holders must obtain prior to next license renewal ( 9/30/06) Negligible fiscal and operational impact on state

More Related